# US 2026/0076361 A1 · Blood preservation compositions, devices, and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076361 A1
- Document ID: US20260076361A1
- Status: Published application
- Kind: A1
- Application number: 19/399,512
- Filed: 2025-11-24
- Published: 2026-03-19
- Earliest claimed: 2018-07-26
- Assignees: Edward Via College of Osteopathic Medicine; Millifluidica LLC
- Applicants: Edward Via College of Osteopathic Medicine
- Inventors: Beverly A. RZIGALINSKI; Siva Sai Ramana Kumar CHALLA
- Web page: https://patentgrep.com/patent/US20260076361A1

## CPC

- A01N 1/146: Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
- A01N 1/12: Chemical aspects of preservation
- A01N 1/126: Physiologically active agents, e.g. antioxidants or nutrients
- A61J 1/065: {Rigid ampoules, e.g. glass ampoules}
- A61J 1/10: Bag-type containers
- A61J 1/1468: {Containers characterised by specific material properties}
- A61L 27/306: {Other specific inorganic materials not covered by A61L27/303 - A61L27/32}
- A61L 27/58: Materials at least partially resorbable by the body
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- B82Y 40/00: Manufacture or treatment of nanostructures
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

Described herein are blood storage containers that can contain a CeONP composition and/or coating on an object surface. In some aspects, the blood storage container can include an insert. In some aspects, the inserts can contain a CeONP composition and/or coating on an object surface. In aspects, the CeONP composition and/or coating on an object surface can be effective to increase the useful storage lifespan of blood, blood product, and/or component thereof stored in the blood storage container. Also described herein are methods of making and using the CeONP compositions, coatings, and devices containing the CeONP compositions and/or coatings described herein.

## Claims

### Claim 1

A blood storage container comprising a blood storage container object surface, comprising:
cerium oxide nanoparticles (CeONPs) present in an amount effective to increase the useful storage life of blood, blood product(s), components thereof, and combinations thereof when such blood, blood product(s), and components thereof are stored in contact with the blood storage container object surface.

### Claim 2 (depends on 1)

The blood storage container of claim 1, wherein the CeONPs are contained in a liquid composition present within the blood storage container and capable of mixing with blood, blood product, or components thereof stored within the blood storage container.

### Claim 3 (depends on 1)

The blood storage container of claim 1, wherein the CeONPs are contained in a solid composition present within the blood storage container and capable of being reconstituted upon mixing with blood, blood product, or components thereof stored within the blood storage container.

### Claim 4 (depends on 2, 3)

The blood storage container of any one of claims 2-3, wherein the concentration of the CeONPs after mixing ranges from about 10 nm to about 100 nm.

### Claim 5 (depends on 4)

The blood storage container as in claim 4, wherein the largest dimension of the CeONPs range from about 2 nm to about 50 nm.

### Claim 6 (depends on 1, 2, 3)

The blood storage container as in any one of claims 1-3, wherein the largest dimension of the CeONPs range from about 2 nm to about 50 nm.

### Claim 7 (depends on 1)

The blood storage container of claim 1, further comprising a coating disposed on one or more areas of the blood container object surface area, wherein the CeONPs form or are part of a composition that forms the coating on the one or more areas of the blood storage container object surface.

### Claim 8 (depends on 7)

The blood storage container of claim 7, wherein the coating is biodegradable.

### Claim 9 (depends on 8)

The blood storage container as in claim 8, wherein the largest dimension of the CeONPs range from about 2 nm to about 50 nm.

### Claim 10 (depends on 7)

The blood storage container as claim 7, wherein the largest dimension of the CeONPs range from about 2 nm to about 50 nm.

### Claim 11 (depends on 1, 7)

The blood storage container as in claim 1 or 7, further comprising an insert, wherein the insert comprises an insert object surface.

### Claim 12 (depends on 11)

The blood storage container of claim 11, wherein the insert comprises one or more openings or voids.

### Claim 13

The blood storage container of 11, wherein the insert object surface comprises a coating, wherein the coating is disposed on one or more areas on the insert object surface and wherein the coating on the insert object surface comprises CeONPs present in an amount effective to increase the useful storage life of blood, blood product(s), components thereof, and combinations thereof when such blood, blood product(s), and components thereof are stored in contact with the insert object surface in the blood storage container.

### Claim 14 (depends on 11)

The blood storage container of claim 11, wherein the coating is biodegradable.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The blood storage container as in any one of claims 1-14, further comprising blood, blood product, blood component and combinations thereof contained within the container.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The blood storage container as in any one of claims 1-15, wherein the blood storage container is a blood storage bag.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A system comprising:
a blood storage container as in any one of claims 1-16.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method comprising:
storing blood, blood product, component thereof, or a combination thereof at a temperature ranging from about −80 degrees C. to about 45 degrees C., wherein the blood, blood product, component thereof, or a combination thereof is contained in a blood storage container as in one of claims 1-16.

### Claim 19 (depends on 18)

The method of claim 18, wherein the temperature ranges from about −80 degrees C. to about 4 degrees C.

### Claim 20 (depends on 18)

The method of claim 18, wherein the temperature ranges from about 5 degrees C. to 29 degrees C.

### Claim 21 (depends on 18)

The method of claim 18, wherein the temperature ranges from 30 degrees C. to about 45 degrees C.

### Claim 22 (depends on 18, 19, 20, 21)

The method of any one of claims 18-21, wherein the step of storing blood, blood product, component thereof, or combination thereof occurs for 1 to 200 days.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method of storing whole blood, the method comprising:
storing the whole blood at a temperature ranging from about −80 degrees C. to about 45 degrees C., wherein the whole blood is contained in a blood storage container as in one of claims 1-16.

### Claim 24 (depends on 23)

The method of claim 23, wherein the temperature ranges from about −80 degrees C. to 4 degrees C. and wherein the whole blood is stored for 1 to 200 days.

### Claim 25 (depends on 23)

The method of claim 23, wherein the temperature ranges from 5 to 29 degrees C. or from 30 to about 45 degrees C. and wherein the whole blood is stored for 1 to 28 days.

### Claim 26 (depends on 23, 24, 25)

The method of any of claims 23-25, further comprising the step of administering the stored whole blood after storage to a subject.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method of storing red blood cells, the method comprising:
storing the red blood cells at a temperature ranging from about −80 degrees C. to about 45 degrees C., wherein the red blood cells are contained in a blood storage container as in one of claims 1-16.

### Claim 28 (depends on 27)

The method of claim 27, wherein the temperature ranges from 5 to 29 degrees C. or from 30 to about 45 degrees C., wherein the red blood cells are stored for 1 to 28 days.

### Claim 29 (depends on 27)

The method of claim 27, wherein the temperature ranges from about −80 degrees C. to 4 degrees C. and wherein the red blood cells are stored for 1 to 200 days.

### Claim 30 (depends on 27, 28, 29)

The method of any of claims 27-29, further comprising the step of administering the stored red blood cells after storage to a subject.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method of storing platelets, the method comprising:
storing the platelets at a temperature ranging from about 5 degrees C. to about 29 degrees C. and wherein the platelets are contained in a blood storage container as in one of claims 1-16.

### Claim 32 (depends on 31)

The method of claim 31, wherein the temperature ranges from 5 to 29 degrees C. or from 30 to about 45 degrees C. and wherein the platelets are stored for 1 to 28 days.

### Claim 33 (depends on 31, 32)

The method of any of claims 31-32, further comprising the step of administering the stored platelets after storage to a subject.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method comprising:
depositing blood, blood product, component(s) thereof, and combinations thereof into a blood storage container as in any one of claims 1-16.

### Claim 35 (depends on 34)

The method of claim 34, further comprising the step of storing the blood storage container for a period of time at a temperature.

### Claim 36 (depends on 35)

The method of claim 35, wherein the period of time ranges from 1 to 200 days.

### Claim 37 (depends on 36)

The method of claim 36, wherein the temperature ranges from about −80 to about 45 degrees C.

### Claim 38 (depends on 35)

The method of claim 35, wherein the temperature ranges from about −80 to about 45 degrees C.

### Claim 39

A blood container insert having an object surface, the insert comprising:
a coating, wherein the coating is disposed on one or more areas on the object surface and wherein the coating on the object surface comprises CeONPs present in an amount effective to increase the useful storage life of blood, blood product(s), components thereof, and combinations thereof when such blood, blood product(s), and components thereof are stored in contact with the insert object surface inside of the blood storage container.

### Claim 40 (depends on 39)

The blood container insert of claim 39, wherein the blood container insert comprises one or more openings or voids.

### Claim 41 (depends on 39, 40)

The blood container insert of any one of claims 39-40, wherein the coating biodegradable.

### Claim 42

An implant having an object surface comprising:
a coating, wherein the coating is disposed on one or more areas on the object surface and wherein the coating on the object surface comprises CeONPs.

### Claim 43 (depends on 42)

A method comprising:
implanting the implant of claim 42 into a subject in need thereof.
